# Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

> **NCT06934447** · PHASE1 · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 18 (estimated)

## Conditions studied

- CAR T Cell Therapy
- Systemic Lupus Erythematosus
- BCMA

## Interventions

- **BIOLOGICAL:** anti-BCMA/CD70-CAR-T cells

## Key facts

- **NCT ID:** NCT06934447
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-25
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06934447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06934447, "Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06934447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*